Install
Drug Discovery & Trials
Targets, biomarkers, AI discovery, and Phases I–III clinical results.
- 19 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
Latest in Drug Discovery & Trials
WBS Activity Coding Structure Simplifies Primavera P6 Schedules｜Himansi Kaur
1+ day, 14+ hour ago (184+ words) In Primavera P6, activity code refers to a label which is assigned to an activity. This label is based on a specific classification. For example, a building project may contain activities for excavation, foundations, structural work, electrical installation, and finishing. Without…...
BioShanghai Week 2026 Opens -- Joining Forces to Build a Global Biopharmaceutical Innovation Ecosystem
13+ hour, 30+ min ago (118+ words) SHANGHAI, Sept. 20, 2026 /PRNewswire/ -- A news report from Yicai Global: On September 17, the BioShanghai Week 2026 opened at Zhangjiang Science Hall in Shanghai. Themed "AI for Biopharma, Health for All," this year's event brings together innovation resources from around the world to…...
AI biotech without humans? Stanford deploys 37,000 agents to hunt new therapies - BusinessToday
23+ hour ago (512+ words) What if an entire biotechnology company could operate without human employees, laboratories or a physical office? Researchers at Stanford Medicine have built a virtual biotech company that uses as many as 37,000 AI agents to work across the drug-development pipeline, from…...
AI framework identifies cannabidiol as a potential ischemic stroke therapy
2+ day, 1+ hour ago (305+ words) eurekalert.org The development of an ML model involving the inclusion of stroke-related biological processes. A research team has developed an artificial intelligence-integrated framework that combines pathway-based machine learning, transcriptomic prediction, and pharmacophore analysis to rapidly identify and optimize therapeutic…...
Stanford creates virtual biotech company with 37,000 AI agents to analyze clinical trials and find new drugs
2+ day, 4+ hour ago (368+ words) Stanford Medicine researchers have created Virtual Biotech, a system that simulates the work of an entire biotech company. Instead of humans, it employs AI agents. AI agents can search for potential targets for new drugs—for example, proteins or genes…...
Novo Nordisk taps Anthropic's Claude to speed drug discovery
1+ day, 23+ hour ago (54+ words) drugdiscoverynews.com Welcome to the Weekly Rundown where the DDN editors cover this week’s top biotech and pharma news. Add Drug Discovery News as a preferred Google source to see more of our trusted coverage. Stay connected with all of…...
Anthropic makes more AI models available to drug researchers
1+ day, 19+ hour ago (11+ words) FirstWord Pharma...
Virtual Biotech Company Puts 37,000 AI Agents to Work on Drug Discovery
1+ day, 21+ hour ago (652+ words) The system, designed by Stanford researchers, identified which drugs are more likely to succeed in trials and even proposed a cancer treatment a major drugmaker later landed on too. Myriam Zilles on Unsplash Developing a new drug can take years…...
BioHealth Capital Region - Regional Life Sciences Roundup - September 18, 2026
2+ day, 5+ hour ago (1223+ words) This week in the BioHealth Capital Region, money is moving, science is advancing, and companies are figuring out what comes next. Across the region, new funding is giving biotech companies more room to grow, clinical programs are reaching important milestones,…...
Nobel laureate-founded MasterSwitch secures NIH backing for HNF4α liver therapy
2+ day, 53+ min ago (262+ words) AllSci MasterSwitch Bio has received a USD 1.19 million SBIR grant from the National Institute of Diabetes and Digestive and Kidney Diseases to advance an HNF4α mRNA therapy for decompensated cirrhosis and end-stage liver disease. The Direct-to-Phase II award will support dose…...